182 related articles for article (PubMed ID: 28376103)
1. Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial.
Komolmit P; Charoensuk K; Thanapirom K; Suksawatamnuay S; Thaimai P; Chirathaworn C; Poovorawan Y
PLoS One; 2017; 12(4):e0174608. PubMed ID: 28376103
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
3. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
Ladero JM; Torrejón MJ; Sánchez-Pobre P; Suárez A; Cuenca F; de la Orden V; Devesa MJ; Rodrigo M; Estrada V; López-Alonso G; Agúndez JA
Ann Hepatol; 2013; 12(2):199-204. PubMed ID: 23396730
[TBL] [Abstract][Full Text] [Related]
5. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
Maes M; Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Meltzer H
Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
[TBL] [Abstract][Full Text] [Related]
6. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
Mandorfer M; Reiberger T; Payer BA; Ferlitsch A; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Trauner M; Peck-Radosavljevic M;
AIDS; 2013 Jan; 27(2):227-32. PubMed ID: 23238552
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
[TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin D supplementation on selected inflammatory biomarkers in older adults: a secondary analysis of data from a randomised, placebo-controlled trial.
Waterhouse M; Tran B; Ebeling PR; English DR; Lucas RM; Venn AJ; Webb PM; Whiteman DC; Neale RE
Br J Nutr; 2015 Sep; 114(5):693-9. PubMed ID: 26206095
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
10. Association of interferon-γ-induced protein-10 serum levels with virological responses to PEG-interferon-based therapy in hepatitis C virus genotype 1 or 2 chronically infected Chinese patients.
Wang J; Jiang D; Rao H; Yang R; Wang Y; Wei L
Scand J Gastroenterol; 2014 Nov; 49(11):1349-58. PubMed ID: 25263691
[TBL] [Abstract][Full Text] [Related]
11. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.
Gabr SA; Alghadir AH; Allam AA; Ajarem J; Al-Basher G; Abdel-Maksoud MA; Ghfar AA; Aboud A
Clin Interv Aging; 2016; 11():523-33. PubMed ID: 27217734
[TBL] [Abstract][Full Text] [Related]
12. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2013 Mar; 40(3):265-72. PubMed ID: 23204220
[TBL] [Abstract][Full Text] [Related]
13. Nutritional vitamin D supplementation in dialysis: a randomized trial.
Bhan I; Dobens D; Tamez H; Deferio JJ; Li YC; Warren HS; Ankers E; Wenger J; Tucker JK; Trottier C; Pathan F; Kalim S; Nigwekar SU; Thadhani R
Clin J Am Soc Nephrol; 2015 Apr; 10(4):611-9. PubMed ID: 25770176
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome.
Sansanayudh N; Wongwiwatthananukit S; Phetkrajaysang N; Krittiyanunt S
Int J Clin Pharm; 2014 Aug; 36(4):771-8. PubMed ID: 24853094
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543
[TBL] [Abstract][Full Text] [Related]
16. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial.
Meireles MS; Kamimura MA; Dalboni MA; Giffoni de Carvalho JT; Aoike DT; Cuppari L
Clin Nutr; 2016 Dec; 35(6):1251-1258. PubMed ID: 27161894
[TBL] [Abstract][Full Text] [Related]
17. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial.
McMullan CJ; Borgi L; Curhan GC; Fisher N; Forman JP
J Hypertens; 2017 Apr; 35(4):822-829. PubMed ID: 28033130
[TBL] [Abstract][Full Text] [Related]
18. Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial.
Hammami MM; Abuhdeeb K; Hammami S; Yusuf A
BMC Endocr Disord; 2019 Jan; 19(1):8. PubMed ID: 30658603
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study.
Komolmit P; Kimtrakool S; Suksawatamnuay S; Thanapirom K; Chattrasophon K; Thaimai P; Chirathaworn C; Poovorawan Y
Sci Rep; 2017 Aug; 7(1):8905. PubMed ID: 28827788
[TBL] [Abstract][Full Text] [Related]
20. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.
Diago M; Castellano G; García-Samaniego J; Pérez C; Fernández I; Romero M; Iacono OL; García-Monzón C
Gut; 2006 Mar; 55(3):374-9. PubMed ID: 16150856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
